Episode 269 - Brian Connelly with TheracosBio

In this episode of Diabetics Doing Things, Rob interviews Brian
Connelly from TheracosBio. Brian shares insights into his
background, the mission of Theracos, and their breakthrough SGLT 2
inhibitor, Brenzavvy. The discussion delves into Brian's journey to
Theracos, his work in the biotech industry, and the mission of
Theracos to provide affordable medications for patients with common
diseases, like type 2 diabetes. Topics discussed: 1. Brian
Connelly's background and journey to TheracosBio. 2. The mission of
TheracosBio to develop affordable medications for patients with
chronic diseases. 3. Introduction to Theracos' breakthrough SGLT 2
inhibitor, Brenzavvy. 4. Challenges in the pharmaceutical industry
regarding drug pricing and accessibility. 5. Impact of Brenzavvy on
patients with type 2 diabetes, focusing on cost, efficacy, and
improved health outcomes. 6. Distribution and accessibility of
Brenzavvy through Cost Plus Drugs and traditional pharmacies. 7.
The importance of alignment within the organization and the
societal impact of providing affordable medications. 8. Addressing
public health concerns, adherence rates, and long-term cost savings
for patients with chronic conditions. Here are key takeaways and
lessons: - TheracosBio is dedicated to providing affordable
medications, like Brenzavvy, to patients with chronic diseases,
such as type 2 diabetes. - Brenzavvy offers cost-effective
treatment options with improved health outcomes for patients.-
Share struggles to create awareness and support within the
community. - The company's mission prioritizes patient access and
affordability over maximizing profits, emphasizing societal impact
and improved public health. - Collaboration with organizations like
Cost Plus Drugs enhances distribution and accessibility of
Brenzavvy to a wider patient population. - The importance of
transparency, patient feedback, and physician awareness in
promoting the use of affordable medications for chronic conditions.
References: https://www.theracosbio.com/ https://www.brenzavvy.com
00:00: Unveiling the Noble Mission of TheracosBio: A Journey from
Feline Diabetes to Human Therapeutics 05:59: Finding Purpose
Through Chronic Illness and Work: A Journey of Passion and
Perseverance 13:02: Revolutionizing Drug Pricing: The Mission of
Theracos in Making Medication Accessible 19:37: Exploring the High
Cost of Diabetes Medication and Solutions 24:28: Addressing
Societal Impact and Accessibility in Diabetes Treatment 29:16:
Challenges and Misconceptions in the Pharmaceutical Industry 33:45:
Building a Mission-Driven Company: The Journey of Theracos CEO
37:57: Revolutionizing Access to Medication: The Success Story of
Brenzavvy 40:58: Unveiling Brenzavvy: The Affordable and Effective
SGLT 2 Inhibitor for Type 2 Diabetes 45:06: Revolutionizing
Healthcare with Low Cost Drugs: A Story of Passion and Purpose